Next 10 |
2024-05-01 07:34:08 ET More on AB Corporate Bond ETF Dividend scorecard for AB Corporate Bond ETF Read the full article on Seeking Alpha For further details see: AB Corporate Bond ETF goes ex dividend today
LONDON, UK / ACCESSWIRE / December 9, 2022 / Kazia Therapeutics has announced the publication of pre-clinical data for its second pipeline asset, EVT801 in the journal Cancer Research Communications. The research was conducted by licensing partner Evotec and was the key driver for Kazia in-licen...
LONDON, UK / ACCESSWIRE / December 7, 2022 / With its H123 interim results, ReNeuron highlighted progress across its proprietary exosome platform, CustomEx. The company reported H123 revenues of £438k (H122: £58k), primarily related to income associated with a £320k payment from F...
WALTHAM, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), (“EyeGate” or the “Company”), a clinical stage specialty pharmaceutical company developing and commercializing products for treating ophthalmic diseases, today announc...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips I’ll start this article the same way that I start every penny stock list: with a caveat and a warning. While penny stocks can provide quick, sustainable returns, investors must be careful. Arguably the best way to d...
3 Penny Stocks To Add to Your October Watchlist If you’re making a list of penny stocks to watch in October, there are plenty of options to choose from. The best way to begin making a penny stocks watchlist is to understand what industries could be worth watching. Right now, ...
Penny Stocks For You List This Month Penny stocks are picking up steam this month. Thanks to a constant search for volatility, these cheap stocks are the shining light amid a sea of red in the broader markets. Some may use ETFs like the Russell Small-Cap ETF ( NYSE:IWM ) to gauge re...
Are Biotech Penny Stocks On Your List This Month? Is it time to revisit biotech penny stocks ? The last few sessions saw a pullback in the overall sector. Both the Nasdaq and S&P Biotech ETFs ( IBB & XBI ) retreated recently. However, biotech has begun heating up tow...
Communications Systems (NASDAQ:JCS) +27% declares $3.50 special dividend NanoViricides (NYSE:NNVC) +21% completes licensing for Coronavirus field which includes current COVID-19 drug development aTyr Pharma (NASDAQ:LIFE) +13%. DatChat (NASDAQ:DATS) +10%. SeaChange International...
WALTHAM, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), (“EyeGate” or the “Company”), a clinical-stage specialty pharmaceutical company developing and commercializing products for treating ophthalmic diseases, today a...
News, Short Squeeze, Breakout and More Instantly...
Eyegate Pharmaceuticals Inc. Company Name:
EYEG Stock Symbol:
NASDAQ Market:
LONDON, UK / ACCESSWIRE / December 9, 2022 / Kazia Therapeutics has announced the publication of pre-clinical data for its second pipeline asset, EVT801 in the journal Cancer Research Communications. The research was conducted by licensing partner Evotec and was the key driver for Kazia in-licen...
LONDON, UK / ACCESSWIRE / December 7, 2022 / With its H123 interim results, ReNeuron highlighted progress across its proprietary exosome platform, CustomEx. The company reported H123 revenues of £438k (H122: £58k), primarily related to income associated with a £320k payment from F...
WALTHAM, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), (“EyeGate” or the “Company”), a clinical stage specialty pharmaceutical company developing and commercializing products for treating ophthalmic diseases, today announc...